WHO has approved the Johnson & Johnson vaccine for emergency use.
This step, as it had already happened in the case of other vaccines, opens the way for the distribution of hundreds of millions of doses to countries that do not have regulatory bodies.
The emergency authorization procedure helps countries that do not have the means to determine the efficacy and safety of a drug on their own to have faster access to therapies and allows the Covax device, set up to ensure equal access vaccine, to begin distribution. The WHO, in these terms, had already authorized Pfizer and AstraZeneca vaccines.
"Each new safe and effective tool against Covid-19 is another step towards pandemic control," WHO chief Tedros Adhanom Ghebreyesus said in a statement.